What should I know about newborn screening?

Newborn Screening: Essential Knowledge for Healthcare Providers

Newborn screening is a comprehensive public health system—not just a test—that requires coordinated education, screening, follow-up, diagnosis, treatment, and program evaluation to prevent permanent disability and death in affected infants. 1

Core Principles You Must Understand

Universal newborn screening is an essential public health responsibility that prioritizes improving health outcomes for affected children above all other considerations. 1 The system must be driven primarily by what benefits the affected newborn, with secondary consideration for unaffected newborns, families, and health professionals. 1

Screening is More Than Just Testing

The complete newborn screening system encompasses six critical components that must work together: 1

• Education of families and healthcare providers about the purpose and process
• Screening performed on dried blood spots collected 24-48 hours after birth 1
• Follow-up to ensure timely communication of results
• Diagnosis through confirmatory testing when screening is positive
• Treatment and management initiated before clinical symptoms appear
• Program evaluation with longitudinal data collection 1

Criteria for Including Conditions in Screening Panels

For a condition to be included as a primary screening target, it must meet three mandatory criteria: 1

1. Detectable in the presymptomatic phase (24-48 hours after birth) when it would not ordinarily be clinically apparent 1
2. Validated testing available with appropriate sensitivity and specificity 1
3. Demonstrated benefits from early detection, timely intervention, and efficacious treatment that improve morbidity and mortality 1

Two-Tier Condition Classification

Programs distinguish between: 1

• Core panel conditions: Meet all three mandatory criteria and warrant mandated screening
• Secondary target conditions: Identified incidentally through multiplex technologies (like tandem mass spectrometry) or as part of differential diagnosis, even if lacking definitive treatment—these must still be reported to families and providers 1

Critical System Requirements

The Medical Home Connection

Close communication between the medical home and public/private screening program components is mandatory to ensure confirmation of test results and appropriate follow-up care. 1 This coordination prevents the most common pitfall: lost-to-follow-up cases where positive screens never reach definitive diagnosis or treatment.

Specimen Management

Newborn screening specimens are valuable health resources requiring: 1

• Confidential storage policies with clear guidelines for appropriate use
• Quality assurance programs for both laboratory and follow-up systems 1
• Standardized reporting procedures across programs 1

Oversight and Quality Standards

Programs must implement: 1

• Enhanced hospital-based screening oversight (e.g., through JCAHO accreditation) to improve tracking of screen-positive cases
• Total quality management applied to all program components 1
• Standardized case definitions and performance standards 1
• Long-term data collection and surveillance for all screen-positive individuals 1

Technology Considerations

Programs should maximize the use of multiplex technologies (particularly tandem mass spectrometry) that can detect multiple conditions simultaneously. 1 This approach identifies not only core panel conditions but also secondary targets and carrier status that have clinical significance. 1

The screening must report all abnormal results associated with clinically significant conditions, including definitive identification of carrier status, even when these are incidental findings. 1

Common Pitfalls to Avoid

Inadequate follow-up systems represent the greatest threat to program effectiveness. Specific vulnerabilities include: 1

• Failure to obtain confirmatory test results after positive screens
• Poor tracking of screen-positive cases through hospital systems
• Lack of standardized language for performance standards (e.g., "repeat test" vs. "second test")
• Insufficient oversight of hospital-based screening activities

Treating screening as only a laboratory function rather than a comprehensive system leads to breakdowns in the education, follow-up, and treatment components. 1

Family Education and Professional Training

Public awareness coupled with professional training and family education is a significant program responsibility that must be integrated into the complete screening system. 1 This includes explaining to families that: 2

• Screening provides early identification before permanent disability or death occurs
• Positive screens require confirmatory testing and do not always mean the child has the condition
• The system requires collaboration among many individuals from blood spot collection through primary care follow-up

National and State Program Structure

While there is no federal mandate requiring states to screen for all conditions on the Recommended Uniform Screening Panel (RUSP), most state public health laboratories have adopted these conditions. 3 The current RUSP includes 34 core conditions. 3

State programs should mandate screening for all core panel conditions and reporting of all secondary target conditions. 1 Programs must also consider that screening benefits extend beyond reducing infant mortality and morbidity to include broader quality of life improvements. 1